Research
Hormonal
GLP-1 receptor agonists have demonstrated efficacy and safety in treating type 2 diabetes and obesity.
GLP-1 receptor agonists can be considered effective options for managing type 2 diabetes and obesity.
StrongSupportsmedium confidence
This class of drugs' efficacy and safety in the treatment of type 2 diabetes and obesity have been demonstrated across multiple large randomized controlled trials.
Why this rating
Based on multiple large randomized controlled trials.
Source
Glucagon-like Peptide-1 Receptor Agonists in the Management of Diabetic Retinopathy
Anindya Samanta et al. · International Ophthalmology Clinics · 2024
reviewCited 6×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →